MYLES DAVID C.

PrivateCIK: 1831216
Location

SAN FRANCISCO, CA

MYLES DAVID C. (Chief Development Officer) sold 16.9% of their position (110K shares) of OLEMA PHARMACEUTICALS, INC. on the open market

Open‑market sale worth $3.11M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 5 sales
InsiderMYLES DAVID C.CIK 1831216
Officer· Chief Development Officer
Since Nov 2020
-110K
Net shares
Net seller
$3.11M
Total sold
5
Open market trades
0B · 5S
9
Total transactions
100K acquired · 210K disposed
Non-Derivative Transactions7

Common Stock

Indirect
S · Sale

Shares

10K

Price / share

$28.34

Trade value

$283.40K

% of position

6.5%
1/12/2026
154.85K144.85K

Common Stock

Direct
M · Option Exercise

Shares

+50K

Price / share

$4.87

Trade value

$243.50K

% of position

9.2%
1/13/2026
542.76K592.76K

Common Stock

Direct
S · Sale

Shares

49.80K

Price / share

$27.60

Trade value

$1.37M

% of position

8.4%
1/13/2026
592.76K542.96K

Common Stock

Direct
S · Sale

Shares

200.00

Price / share

$28.49

Trade value

$5.70K

% of position

0.0%
1/13/2026
542.96K542.76K

Common Stock

Direct
M · Option Exercise

Shares

+50K

Price / share

$4.87

Trade value

$243.50K

% of position

9.2%
1/14/2026
542.76K592.76K

Common Stock

Direct
S · Sale

Shares

15K

Price / share

$28.60

Trade value

$428.91K

% of position

2.5%
1/14/2026
592.76K577.76K

Common Stock

Direct
S · Sale

Shares

35K

Price / share

$28.99

Trade value

$1.01M

% of position

6.1%
1/14/2026
577.76K542.76K
Total

Net shares

10K

Net value

-$2.62M

Derivative Transactions2

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

50K shares

Shares

50K

Strike price

4.87

Held after

100K

Exercisable

1/13/2026

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

50K shares

Shares

50K

Strike price

4.87

Held after

50K

Exercisable

1/14/2026
Non-Derivative Holdings (Post-Transaction)1

Common Stock

Indirect
Shares owned12.83K
Total
12.83K indirect12.83K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
MYLES DAVID C. — Insider Transaction (Form 4) Filed Jan 14, 2026 | Finecho